FDA Inspection 1293402 — BeOne Medicines USA, Inc.
The FDA completed an inspection of BeOne Medicines USA, Inc. on November 6, 2025 in Pennington, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 6, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pennington, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)